Article
Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2…
Drug Design, Development and Therapy · 2022 · Yang L, Shen Q, Hu C, Wang Y, Zhu X, Shu S, Luo Z
Key facts
| Title | Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects |
|---|---|
| First author | Yang L, Shen Q, Hu C, Wang Y, Zhu X, Shu S, Luo Z |
| Journal | Drug Design, Development and Therapy |
| Published | Nov 8, 2022 |
| DOI | 10.2147/DDDT.S387508 |
| Devices mentioned | 021119, K080874, K831119 |
| Product codes mentioned | CIT, CIX, FZS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1